TC
ELV icon

Telemus Capital’s Elevance Health ELV Stock Holding History

Telemus Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-993
Closed -$457K – 328
2023
Q1 		$457K Sell
993
-16
-2% -$7.61K 0.04% 227
2022
Q4 		$480K Buy
1,009
+101
+11% +$51.3K 0.04% 228
2022
Q3 		$412K Sell
908
-206
-18% -$98.6K 0.04% 220
2022
Q2 		$538K Sell
1,114
-345
-24% -$171K 0.05% 232
2022
Q1 		$717K Sell
1,459
-8
-0.5% -$3.66K 0.06% 201
2021
Q4 		$680K Buy
1,467
+25
+2% +$10.5K 0.05% 215
2021
Q3 		$538K Hold
1,442
– – 0.05% 229
2021
Q2 		$551K Buy
1,442
+20
+1% +$7.64K 0.04% 233
2021
Q1 		$505K Sell
1,422
-75
-5% -$24.1K 0.03% 270
2020
Q4 		$481K Hold
1,497
– – 0.04% 261
2020
Q3 		$444K Buy
1,497
+35
+2% +$9.42K 0.03% 325
2020
Q2 		$373K Hold
1,462
– – 0.03% 310
2020
Q1 		$430K Sell
1,462
-178
-11% -$48.5K 0.04% 268
2019
Q4 		$495K Sell
1,640
-200
-11% -$55K 0.04% 249
2019
Q3 		$442K Sell
1,840
-23
-1% -$6.3K 0.04% 259
2019
Q2 		$528K Sell
1,863
-300
-14% -$81.9K 0.05% 231
2019
Q1 		$621K Sell
2,163
-2,455
-53% -$710K 0.05% 247
2018
Q4 		$1.21M Sell
4,618
-101
-2% -$27.8K 0.1% 153
2018
Q3 		$1.29M Sell
4,719
-3,260
-41% -$846K 0.1% 160
2018
Q2 		$1.9M Buy
7,979
+735
+10% +$170K 0.15% 126
2018
Q1 		$1.59M Sell
7,244
-87
-1% -$20.4K 0.13% 144
2017
Q4 		$1.65M Buy
7,331
+644
+10% +$137K 0.13% 137
2017
Q3 		$1.27M Sell
6,687
-2,742
-29% -$522K 0.14% 111
2017
Q2 		$1.77M Buy
9,429
+397
+4% +$71.3K 0.18% 97
2017
Q1 		$1.49M Buy
9,032
+3,037
+51% +$483K 0.16% 107
2016
Q4 		$862K Sell
5,995
-433
-7% -$58K 0.12% 136
2016
Q3 		$805K Buy
6,428
+1,880
+41% +$243K 0.09% 165
2016
Q2 		$597K Buy
4,548
+2,200
+94% +$301K 0.07% 189
2016
Q1 		$326K Buy
+2,348
New +$314K 0.05% 243

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Telemus Capital's ELV Position: Q2 2023 in Review

Telemus Capital sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 993 shares — an estimated $457K sold.

Telemus Capital first reported a position in ELV in Q1 2016 and held it in 29 quarters. The position peaked at $1.9M in Q2 2018. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Telemus Capital reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Telemus Capital sold 993 Elevance Health shares in Q2 2023, an estimated $457K.
  • Telemus Capital first reported a position in Elevance Health in Q1 2016 and held it in 29 quarters.
  • Telemus Capital's Elevance Health position peaked at $1.9M in Q2 2018.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Telemus Capital's 13F filing for Q2 2023, filed 10 Jul 2023.